CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25
- Product NDC
- 49527-080
- 11-digit product format
- 495270080
- Labeler code
- 49527
- Product ID
- 49527-080_0818396d-cc21-00ac-e063-6394a90a5d82
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- TITANIUM DIOXIDE, ZINC OXIDE
- Dosage form
- LIQUID
- Route
- TOPICAL
- Labeler
- CLINIQUE LABORATORIES LLC
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-09-24
- Substance
- TITANIUM DIOXIDE; ZINC OXIDE
- Active strength
- 24; 59 mg/mL; mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 49527-080 | 49527-080-03 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 302b2466d912… | e7b80fea0513… |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f764e8902f78… | 92046438deef… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 68b1e3bced9e… | 98a755eb8bc6… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… | |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… | |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… | |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 49527-080-03 | D | Discontinued by firm | excluded / ndc_excluded.zip | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… | |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… | |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished package | package | 49527-080-00 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TITANIUM DIOXIDE | 24 mg/mL |
| ZINC OXIDE | 59 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 15FIX9V2JP | Internal UNII lookup |
| SOI2LOH54Z | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 884abba1-891d-4c3c-b203-38a5a8a57756 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49527-080-01 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 30 mL in 1 BOTTLE | LIQUID | 30 | 13 | |
| 49527-080-01 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 1 in 1 CARTON | LIQUID | 1 | 13 | |
| 49527-080-02 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 1 in 1 CARTON | LIQUID | 1 | 13 | |
| 49527-080-02 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 5 mL in 1 TUBE | LIQUID | 5 | 13 | |
| 49527-080-03 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 | 0.2 mL in 1 PACKET | LIQUID | 0.2 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49527-080 | CLINIQUE EVEN BETTER CLINICAL SERUM FOUNDATION BROAD SPECTRUM SPF 25 (TITANIUM DIOXIDE, ZINC OXIDE) LIQUID [CLINIQUE LABORATORIES LLC] | 13 | Current NDC, Legacy NDC, 5 package rows | 20231020_884abba1-891d-4c3c-b203-38a5a8a57756.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2000DL-CL30T | SPF30 BS TROPICAL | Epic Laboratories, LLC | 0286f94e-a2e8-b529-e063-6294a90ac08d | 2026-03-02 | Warnings | M020 |
| 2000DL-CL30V | SPF30 BS ORIGINAL | Epic Laboratories, LLC | 1872eefd-d702-ac9f-e063-6294a90a24ef | 2026-03-02 | Warnings | M020 |
| JAYSUING White Birch Moisturizing Sunscreen Cream | TITANIUM DIOXIDE | Shantou Jaysuing Cleaning and Environmental Protection Technology Co., Ltd. | 4c174691-cc32-b2e4-e063-6294a90a0f73 | 2026-03-02 | Warnings | M020 |
| Kypris Pot of Shade Heliotropic Broad Spectrum SPF 30 Sunscreen And Primer | ZINC OXIDE | Kypris Beauty LLC | a5d5f7bd-d7bf-4a5c-8530-b9d5d74754c3 | 2026-02-27 | Warnings | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Chain Drug Marketing Association | 6307627a-94e2-47ea-8519-68975716dd6e | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Sport Sunscreen SPF 30 | AVEBONZONE, HOMOSALATE, OCTISALATE | Chain Drug Marketing Association | a38e150e-2e50-4936-ae46-408f9cf82d15 | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Sport Sunscreen SPF 70 | AVOBENZONE, HOMOSALATE, OCTISALATE | Chain Drug Marketing Association | 87811c86-19d2-4179-8d22-2aeb4680ff57 | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Sunscreen for Kids SPF 50 | AVEBONZONE, HOMOSALATE, OCTISALATE | Chain Drug Marketing Association | d7215a32-00a9-4b70-8597-8ea91f546c1e | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Sport Sunscreen SPF 50 | AVEBONZONE, HOMOSALATE, OCTISALATE | Chain Drug Marketing Association | 9fccccd4-2d2e-4812-85b1-bbeb44ff04ea | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | The Kroger Co. | be702a3b-1652-4468-803d-295100d3e3e2 | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | The Kroger Co. | 644ec129-15c9-4ac1-8362-5b4c2e58ab9a | 2026-02-27 | Warnings, Adverse reactions | M020 |
| SPF Beauty | SPF BEAUTY | Walmart Inc. | f06f26af-81d6-4603-b377-fd12430ec952 | 2026-02-27 | Warnings, Adverse reactions | M020 |
| SPF Moisturizer | SPF MOISTURIZER | Walmart Inc. | 41de3171-9ed3-45da-96fb-dfcf41912229 | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Facial Moisturizer | DAILY FACIAL MOISTURIZER SPF 15 | Walmart Inc. | 2cec9c90-2e64-f005-e063-6294a90a8753 | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Avobenzone, Homosalate, Octisalate | AVOBENZONE, HOMOSALATE, OCTISALATE | Walmart Inc. | 309d881d-40e0-37bc-e063-6294a90a3769 | 2026-02-27 | Warnings, Adverse reactions | M020 |
| Avbenzone, Homosalate, Octisalate | AVBENZONE, HOMOSALATE, OCTISALATE | Walmart Inc. | d3d7a5d3-5c78-45c3-ba4b-7ac1a3b4526a | 2026-02-27 | Warnings | M020 |
| MELAO Sunscreen Stick | ETHYLHEXYL METHOXYCINNAMATE, HOMOSALATE, OCTOCRYLENE, AVOBENZONE | Guangdong Aimu Biological Technology Co., Ltd | 4ba15c03-0409-918b-e063-6294a90ac6ee | 2026-02-26 | Warnings | M020 |
| TIBENA EVERY DAY REAL SUN BLOCK | TITANIUM DIOXIDE, ZINC OXIDE | KONAD CO LTD | 211c9930-4f91-cf8f-e063-6394a90a97b3 | 2026-02-26 | Warnings | M020 |
| Olay Regenerist Whip Lightweight Moisturizer with Sunscreen Broad Spectrum SPF 25 | AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE | The Procter & Gamble Manufacturing Company | 4bbc0639-3a80-1c28-e063-6394a90a3c00 | 2026-02-26 | Warnings | M020 |
| CLE DE PEAU BEAUTE RADIANT FLUID FOUNDATION MATTE M B10 | TITANIUM DIOXIDE | Shiseido Americas Corporation | 54f8210f-4934-4ada-89c3-aa89e7a09260 | 2026-02-26 | Warnings | M020 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 49527-080-01 | 49527008001 | 1 BOTTLE in 1 CARTON (49527-080-01) / 30 mL in 1 BOTTLE | 1 bottle | 2020-09-24 | 0000-00-00 | No | No | Current |
| 49527-080-02 | 49527008002 | 1 TUBE in 1 CARTON (49527-080-02) / 5 mL in 1 TUBE | 1 tube | 2022-06-06 | 0000-00-00 | No | No | Current |
| 49527-080-03 | 49527008003 | .2 mL in 1 PACKET (49527-080-03) | 2022-11-30 | 0000-00-00 | Yes | No | Current |